Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q1- Text added to 2019 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
AstraZeneca, attract, Blaise, budesonide, Code, Coleman, Coughlin, disaggregated, embedded, entecavir, entirety, ethyl, excise, fluoxetine, flutamide, fumarate, Handa, hydroxyurea, inactive, inline, Irish, labetalol, leadership, Maletta, Matthew, Ministry, Missouri, multinational, NEO, Nevakar, Oklahoma, outlined, preliminarily, progressing, qualitative, quantitative, Quebec, reasserted, recipient, Regent, regime, retroactive, saving, Seroquel, Terrance, text, thereunder, thirty, transformational, turnaround, unearned, upheld, Vice, XR
Removed:
achieve, advisory, agent, allegedly, Analgesic, Anesthetic, careful, ceased, chain, complexity, consultation, coordinate, core, covering, decided, decline, delayed, FFDCA, harm, historic, implemented, incentive, intention, labeling, large, marketable, marketed, meeting, modification, monitor, NDA, negatively, orderly, outweigh, point, practice, publicly, refusal, restated, safety, satisfy, Seiyaku, shift, substance, support, Teikoku, traded, unapproved, unrealized, voted, withdraw, withdrawal, work, write, written
Valuein 2019 Q1 filing- Value in 2019 Q2 filing
Original filings
Filing view